Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
The Henry Ford Health System is receiving additional supplies of monoclonal antibodies from the federal government in an effort to hold down COVID-19 hospitalizations that are threatening to overwhelm Detroit area hospitals, the Detroit-based system said Thursday.
Shri Nitin Gadkari, Honourable Union Minister for Road Transport & Highways Micro, Small and Medium Enterprises - Government of India presided as Chief Guest of Honour for the virtual Closing Ceremony of the Global Online Certification Course on Supply Chain Digitization and Management, that was conducted by the National Institute of Industrial Engineering (NITIE), Mumbai. The closing ceremony marked the completion of the immensely successful virtual course that was launched in January, 2.
BOSTON--(BUSINESS WIRE)--The Institute for Healthcare Improvement (IHI) and the DAISY Foundation have announced the recipients of the 2021 DAISY Awards for Extraordinary Nurses in Patient Safety, presented in collaboration with IHI. Christa Bedford-Mu, MSN, RN, CNS, CCRN, C-ELBW, receives the individual award. Co-recipients of the team award include the ICU Nursing Team at Swedish Edmonds hospital and the Faith Community Nurses Team at Emory Saint Joseph’s Hospital.
On Tuesday, the FDA and CDC recommended pausing the administration of the Johnson & Johnson COVID vaccine while the agencies investigate an extremely rare possible side effect. Six women in the U.S. who received the J&J vaccine — all between the ages of 18 and 28 — experienced a blood- clotting disorder called cerebral venous sinus thrombosis in the days after getting their shots, and one has died. It’s not yet clear if the clots were related to the vaccine, though a similar disorder has occurred abroad among some recipients of the AstraZeneca COVID vaccine, which uses the same adenovirus-vector technology as Johnson & Johnson’s. As scientists continue to research the cases to determine if and how they may be related to the shot, U.S. regulators’ sudden decision to pause J&J’s distribution has prompted widespread reaction from across the COVID-expert community. Below is an overview of what they are saying.
India's delayed response in regulatory clearance and government-sponsored acquisitions of the mRNA-based Covid vaccines could mean months of extended wait in the markets.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine